Clinical Trial Update: Evaluating Newly Approved Drugs for Multidrug-resistant TB [Phase 3]

View source ↗

Summary

Phase 3 clinical trials evaluating newly approved drugs for multidrug-resistant tuberculosis have completed, according to a trial update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug-resistant Tuberculosis
• Pulmonary Tuberculosis
• Tuberculosis

Snippet

Sponsor: Médecins Sans Frontières, France | Conditions: Tuberculosis, Multidrug-Resistant, Infection, Bacterial | Phase 3 | Status: COMPLETED